Optimal anemia management reduces cardiovascular morbidity, mortality, and costs in chronic kidney disease
- 1 October 2005
- journal article
- review article
- Published by Elsevier in Kidney International
- Vol. 68 (4) , 1432-1438
- https://doi.org/10.1111/j.1523-1755.2005.00554.x
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Erythropoietin in cardiovascular diseasesPublished by Oxford University Press (OUP) ,2004
- Anemia of chronic disease: Past, present, and futureKidney International, 2003
- The cardio-renal anaemia syndrome: does it exist?Nephrology Dialysis Transplantation, 2003
- Recombinant erythropoietin in clinical practicePublished by Oxford University Press (OUP) ,2003
- THE CLINICAL EPIDEMIOLOGY OF CARDIOVASCULAR DISEASES IN CHRONIC KIDNEY DISEASE: Clinical Epidemiology of Cardiac Disease in Dialysis Patients: Left Ventricular Hypertrophy, Ischemic Heart Disease, and Cardiac FailureSeminars in Dialysis, 2003
- United States Renal Data System assessment of the impact of the National Kidney Foundation-Dialysis Outcomes Quality Initiative guidelinesAmerican Journal of Kidney Diseases, 2002
- Left ventricular alterations and end‐stage renal diseaseNephrology Dialysis Transplantation, 2002
- Prevalence and Management of Anemia Among Patients with Chronic Kidney Disease in a Health Maintenance OrganizationDisease Management and Health Outcomes, 2002
- Trends in anemia at initiation of dialysis in the United StatesKidney International, 2001
- Anemia: An early complication of chronic renal insufficiencyAmerican Journal of Kidney Diseases, 2001